News & Updates

Dubai Creative Clusters Authority signs agreement with Ministry of Health and Prevention

Dubai Creative Clusters Authority (DCCA), a government regulatory body mandated to foster the economic development of Dubai's creative clusters and related knowledge industries, has signed a partnership agreement with the UAE Ministry of Health and Prevention to support the country's efforts in developing the healthcare sector and providing an enabling environment for advancing the pharmaceuticals industry. The new partnership aligns with efforts by DCCA and the Ministry of Health and Prevention to boost the pharmaceuticals industry. It will also strengthen…

Intensify scientific research, use qualified human capital to improve public health, urges VP

Relevant authorities should intensify efforts and employ capable human resources to focus on conducting scientific researches and studies in the healthcare sector, and keep pace with the latest developments in medical technology and equipment, treatment techniques, medicines and rare surgeries that all contribute towards enhancing public health, urged Vice President and Prime Minister and Ruler of Dubai, His Highness Sheikh Mohammed bin Rashid Al Maktoum. His Highness said that the healthcare sector, which is the most important in Dubai and…

DHCC establishes Emirates Reference Laboratory

Dubai Healthcare City (DHCC) announced the launch of the Emirates Reference Laboratory (ERL) under the directives of Vice-President and Prime Minister of the UAE and Ruler of Dubai His Highness Sheikh Mohammed bin Rashid Al Maktoum. In line with HH Sheikh Mohammed's vision, the laboratory, which is a key part of DHCC, will provide UAE and GCC patients with access to efficient, reliable and cost-effective pathology testing services, in addition to specialized services that are currently unavailable in the region.…

Arterys receives FDA clearance for Cardio DLTM application

Arterys, a pioneer in cloud-based medical imaging software, has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its Arterys Cardio DLTM application. Arterys Cardio DLTM is the first technology to be cleared by the FDA that leverages cloud computing and deep learning in a clinical setting. Arterys Cardio DLTM provides automated, editable ventricle segmentations based on conventional cardiac MRI images that are as accurate as segmentations performed manually by experienced physicians. The US clearance complements…